1. Home
  2. JAGX vs OCTO Comparison

JAGX vs OCTO Comparison

Compare JAGX & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • OCTO
  • Stock Information
  • Founded
  • JAGX 2013
  • OCTO 1966
  • Country
  • JAGX United States
  • OCTO United States
  • Employees
  • JAGX N/A
  • OCTO N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • OCTO
  • Sector
  • JAGX Health Care
  • OCTO
  • Exchange
  • JAGX Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • JAGX 3.9M
  • OCTO 4.2M
  • IPO Year
  • JAGX N/A
  • OCTO N/A
  • Fundamental
  • Price
  • JAGX $1.77
  • OCTO $1.45
  • Analyst Decision
  • JAGX Strong Buy
  • OCTO
  • Analyst Count
  • JAGX 1
  • OCTO 0
  • Target Price
  • JAGX $60.00
  • OCTO N/A
  • AVG Volume (30 Days)
  • JAGX 147.1K
  • OCTO 32.5K
  • Earning Date
  • JAGX 08-14-2025
  • OCTO 08-19-2025
  • Dividend Yield
  • JAGX N/A
  • OCTO N/A
  • EPS Growth
  • JAGX N/A
  • OCTO N/A
  • EPS
  • JAGX N/A
  • OCTO N/A
  • Revenue
  • JAGX $11,810,000.00
  • OCTO $43,871,615.00
  • Revenue This Year
  • JAGX $22.41
  • OCTO N/A
  • Revenue Next Year
  • JAGX $30.00
  • OCTO N/A
  • P/E Ratio
  • JAGX N/A
  • OCTO N/A
  • Revenue Growth
  • JAGX 15.96
  • OCTO N/A
  • 52 Week Low
  • JAGX $1.57
  • OCTO $0.98
  • 52 Week High
  • JAGX $35.25
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 39.90
  • OCTO 47.84
  • Support Level
  • JAGX $1.60
  • OCTO $1.35
  • Resistance Level
  • JAGX $1.70
  • OCTO $1.51
  • Average True Range (ATR)
  • JAGX 0.12
  • OCTO 0.10
  • MACD
  • JAGX 0.01
  • OCTO -0.01
  • Stochastic Oscillator
  • JAGX 37.04
  • OCTO 46.15

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.

Share on Social Networks: